1. Home
  2. HFFG vs RCEL Comparison

HFFG vs RCEL Comparison

Compare HFFG & RCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo HF Foods Group Inc.

HFFG

HF Foods Group Inc.

HOLD

Current Price

$2.25

Market Cap

127.8M

ML Signal

HOLD

Logo Avita Medical Inc.

RCEL

Avita Medical Inc.

HOLD

Current Price

$3.42

Market Cap

102.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HFFG
RCEL
Founded
1997
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Food Distributors
Medical/Dental Instruments
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
127.8M
102.5M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
HFFG
RCEL
Price
$2.25
$3.42
Analyst Decision
Buy
Analyst Count
0
4
Target Price
N/A
$8.67
AVG Volume (30 Days)
113.1K
197.9K
Earning Date
11-10-2025
02-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$1,225,541,000.00
$72,401,000.00
Revenue This Year
$4.36
$13.12
Revenue Next Year
$3.35
$27.56
P/E Ratio
N/A
N/A
Revenue Growth
4.10
20.59
52 Week Low
$1.70
$3.25
52 Week High
$4.93
$14.16

Technical Indicators

Market Signals
Indicator
HFFG
RCEL
Relative Strength Index (RSI) 43.30 41.28
Support Level $2.10 $3.36
Resistance Level $2.29 $3.61
Average True Range (ATR) 0.12 0.18
MACD -0.02 0.03
Stochastic Oscillator 26.79 34.78

Price Performance

Historical Comparison
HFFG
RCEL

About HFFG HF Foods Group Inc.

HF Foods Group Inc is an Asian food service distributor that markets and distributes fresh produce, seafood, frozen and dry food, and non-food products to Asian restaurants and other food service customers throughout the United States. The company's business consists of one operating segment; HF Group, which operates solely in the United States. The company's customer base consists of Chinese and Asian restaurants, and it provides sales and service support to customers who mainly converse in Mandarin or Chinese dialects.

About RCEL Avita Medical Inc.

Avita is a single product company. Its RECELL system is an innovative burn treatment device which creates Spray-on Skin from a small skin sample within 30 minutes, thus avoiding or reducing the need for skin grafts. It's approved for the treatment of adult and paediatric patients in the US and an expanded indication for soft-tissue reconstruction. It is currently in rollout across the approximately 136 US burn centers. Despite having product approval in Australia, Europe, Canada, and China, Avita is not actively marketing in those territories and focussing instead on the US region. However, it is expected to launch in Japan via distribution partner Cosmotec in second-half fiscal 2022. Avita is domiciled, and has its primary listing, in the US.

Share on Social Networks: